The SH2B3 and KCNK5 loci may be implicated in regulation of platelet count, volume, and maturity

Morten K Christiansen1, Sanne B Larsen2, Mette Nyegaard3

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; Faculty of Health, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Thrombosis Research
|September 3, 2017
PubMed

Insights

Genetic variants linked to coronary artery disease influence platelet production and size. KCNK5 impacts platelet volume and maturity, while SH2B3 affects platelet count and thrombopoietin levels.

Area of Science:

  • Cardiovascular Genetics
  • Hematology
  • Thrombopoiesis Research

Background:

  • Genome-wide association studies (GWAS) have identified genetic variants associated with coronary artery disease (CAD) and myocardial infarction (MI).
  • The functional role of these CAD/MI-associated variants in thrombopoiesis remains largely unexplored.
  • Understanding genetic links to platelet function is crucial for cardiovascular health.

Purpose of the Study:

  • To investigate the association between genetic variants implicated in CAD/MI and key thrombopoiesis indices.
  • To examine the relationship between CAD/MI genetic markers and platelet count (PC), mean platelet volume (MPV), immature platelet count (IPC), immature platelet fraction (IPF), and serum thrombopoietin (TPO).

Main Methods:

  • Genotyping of 45 genome-wide significant CAD/MI markers in 879 stable CAD patients.
  • Calculation of a genetic risk score to evaluate combined risk from identified variants.
  • Analysis of platelet indices using the Sysmex XE-2100 haematology analyser and TPO levels via ELISA.

Main Results:

  • The variant rs10947789 (KCNK5) showed associations with increased MPV, IPC, and IPF, and decreased TPO.
  • The variant rs3184504 (SH2B3) was linked to higher PC and lower TPO.
  • A significant association was found between SH2B3 and decreased IPC, but not IPF.

Conclusions:

  • KCNK5 plays a novel role in regulating platelet size and maturity.
  • The SH2B3 locus is confirmed to be associated with platelet count.
  • These findings link CAD/MI genetic risk factors to specific mechanisms of platelet production and function.
Abstract

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.0K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.3K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.9K